ANGELA HUBBARD
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HAZARD, KY NPI 1164094850
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family KY Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$495.40
- Category: General Payments
- Program years: PY2021–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $138.34 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $138.34 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $57.88 | 3 |
| ITI, Inc. | $21.64 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.06 | 1 |
| Lilly USA, LLC | $15.70 | 1 |
| Acerta Pharma LLC | $13.99 | 1 |
| Corcept Therapeutics | $13.07 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105813059 | AstraZeneca Pharmaceuticals LP | $13.99 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117763331 | Corcept Therapeutics | $13.07 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117896770 | Boehringer Ingelheim Pharmaceuticals, Inc. | $16.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119098758 | Otsuka America Pharmaceutical, Inc. | $14.51 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119098760 | Otsuka America Pharmaceutical, Inc. | $21.93 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119098762 | Otsuka America Pharmaceutical, Inc. | $21.44 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135514412 | Lilly USA, LLC | $15.70 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143505549 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.64 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.